Affiliation: | Ochsner Clinic Foundation, New Orleans, Louisiana, USA (A.K. Feehan, C. Velasco, D. Fort, J.H. Burton, E.G. Price-Haywood, J. Garcia-Diaz, L. Seoane);The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans (A.K. Feehan, E.G. Price-Haywood, J. Garcia-Diaz, L. Seoane);Pennington Louisiana State University, Baton Rouge, Louisiana, USA (P.T. Katzmarzyk);Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, USA (L. Seoane) |
Abstract: | By using paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined point prevalence and seroprevalence in Louisiana, USA, during the second phase of reopening. Infections were highly variable by race and ethnicity, work environment, and ZIP code. Census-weighted seroprevalence was 3.6%, and point prevalence was 3.0%. |